Publikationen von C. Sievers
Alle Typen
Zeitschriftenartikel (56)
2012
Zeitschriftenartikel
15 (3), S. 350 - 357 (2012)
Cognitive function in acromegaly: description and brain volumetric correlates. Pituitary
Zeitschriftenartikel
167 (3), S. 327 - 335 (2012)
Polymorphisms of the drug transporter gene: ABCB1 predict side effects of treatment with cabergoline in patients with PRL adenomas. European Journal of Endocrinology
Zeitschriftenartikel
16 (1), S. 80 - 82 (2012)
A case of an acromegalic patient resistant to the recommended maximum GH receptor antagonist dosage. Hippokratia 2011
Zeitschriftenartikel
60 (10), S. 1363 - 1371 (2011)
Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort. Metabolism-Clinical and Experimental
Zeitschriftenartikel
165 (4), S. 509 - 515 (2011)
High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. European Journal of Endocrinology
Zeitschriftenartikel
96 (7), S. 2074 - 2080 (2011)
A Novel Approach to the Detection of Acromegaly: Accuracy of Diagnosis by Automatic Face Classification. Journal of Clinical Endocrinology & Metabolism
Zeitschriftenartikel
21 (2), S. 102 - 106 (2011)
All-cause mortality and serum insulin-like growth factor I in primary care patients. Growth Hormone & IGF Research 2010
Zeitschriftenartikel
20 (5), S. 338 - 344 (2010)
The acute effect of a single application of cabergoline on endogenous GH levels in patients with acromegaly on pegvisomant treatment. Growth Hormone & IGF Research
Zeitschriftenartikel
163 (4), S. 699 - 708 (2010)
Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients. European Journal of Endocrinology
Zeitschriftenartikel
13 (3), S. 207 - 214 (2010)
Adverse anthropometric risk profile in biochemically controlled acromegalic patients: comparison with an age- and gender-matched primary care population. Pituitary
Zeitschriftenartikel
1, doi:10.3389/fneur.2010.00148 (2010)
Triglycerides and stroke risk prediction: lessons from a prospective cohort study in german primary care patients. Frontiers in Neurology
Zeitschriftenartikel
164 (2), S. 223 - 229 (2010)
Prediction of incident diabetes mellitus by baseline insulin-like growth factor-l levels. European Journal of Endocrinology
Zeitschriftenartikel
73 (1), S. 89 - 94 (2010)
Change of symptoms and perceived health in acromegalic patients on pegvisomant therapy: a retrospective cohort study within the German Pegvisomant Observational Study (GPOS). Clinical Endocrinology (Oxford) 2009
Zeitschriftenartikel
117 (10), S. 660 - 660 (2009)
Predictors of neuropsychiatric side effects and therapy response of dopamine agonist therapy in patients with prolactinomas: a clinical study concept. Experimental and Clinical Endocrinology & Diabetes
Zeitschriftenartikel
117 (10), S. 660 - 661 (2009)
Comorbidities in transsexual patients under hormonal treatment in comparison with a control group sampled from the DETECT-cohort. Experimental and Clinical Endocrinology & Diabetes
Zeitschriftenartikel
117 (10), S. 661 - 662 (2009)
Depression, anxiety and quality of life in patients with Cushing's disease compared to controls with non-functioning pituitary adenomas. Experimental and Clinical Endocrinology & Diabetes
Zeitschriftenartikel
117 (10), S. 664 - 664 (2009)
The acute effect of a single application of cabergoline on endogenous GH levels in patients with acromegaly on pegvisomant treatment. Experimental and Clinical Endocrinology & Diabetes
Zeitschriftenartikel
71 (5), S. 691 - 701 (2009)
Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients. Clinical Endocrinology
Zeitschriftenartikel
117 (10), S. 659 - 659 (2009)
Testosterone levels in relation to cardiovascular risk factors and cardiovascular events in women; a cross-sectional and prospective cohort study in German primary care patients. Experimental and Clinical Endocrinology & Diabetes
Zeitschriftenartikel
125 (9), S. 2122 - 2126 (2009)
Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly. International Journal of Cancer